HCW Biologics Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -5.5 | -100% |
| P/S |
|
14.29 | 33.44 | -57.27% |
|
|
| P/BV |
|
3.02 | 4.64 | -35.05% |
|
|
| P/FCF |
|
0 | 42.53 | -100% |
|
|
| Ev/Ebitda |
|
-1.77 | -17.68 | -90% |
|
|
| Ev/S |
|
15.29 | 22.59 | -32.32% |
|
|
| Ev/FCF |
|
-1.51 | 47.55 | -103.18% |
|
|
| E/P |
|
0 | 0.0182 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-865.02 | -14.2 | 5990.06% | -469.2 | +84.36% |
| ROE |
|
-185.67 | 9.78 | -1997.94% |
|
|
| ROA |
|
-87.66 | 0.33 | -26658.86% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-879.52 | -26.41 | 3229.77% |
|
|
| ROCE |
|
-191.04 | 14.55 | -1413.08% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2624 | -3.87 | -93.22% | -0.2705 | -2.99% |
| Nеt Debt/Ebitda |
|
-0.1162 | -4.24 | -97.26% |
|
|
| Debt/Ratio |
|
0.2263 | 0.1853 | 22.11% |
|
|
| Debt/Equity |
|
0.5973 | 1.61 | -62.82% |
|
|
| Debt/Net Income |
|
-0.2581 | 10.06 | -102.57% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-30.69 | 30.62 | -200.23% | ||
| Growth impulse Ebitda in 5 years |
|
241.68 | -17.42 | -1487.37% | ||
| Growth impulse Net Income in 5 years |
|
247.14 | -52.26 | -572.9% | ||
| Growth impulse FCF in 5 years |
|
250.2 | -31.68 | -889.77% | ||
| Growth impulse EPS in 5 years |
|
135.33 | -61.82 | -318.91% |
IP Score
4.39/10
